MFDS — authorised 29 September 2021
- Marketing authorisation holder: MIRUM PHARMA INC
- Status: likely_approved
🇰🇷 Livmarli in South Korea
MFDS authorised Livmarli on 29 September 2021
Marketing authorisation
Livmarli in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in South Korea
Frequently asked questions
Is Livmarli approved in South Korea?
Yes. MFDS authorised it on 29 September 2021.
Who is the marketing authorisation holder for Livmarli in South Korea?
MIRUM PHARMA INC holds the South Korean marketing authorisation.